Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database Study

BACKGROUND: Thiopurines are the prerequisite for immunomodulation in inflammatory bowel disease (IBD) therapy. When administered in high (oncological) dose, thiopurine metabolites act as purine antagonists, causing DNA-strand breakage and myelotoxicity. In lower IBD dosages, the mode of action is pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Drug Monit
Autors principals: Meijer, Berrie, Wilhelm, Abraham J., Mulder, Chris J. J., Bouma, Gerd, van Bodegraven, Adriaan A., de Boer, Nanne K. H.
Format: Artigo
Idioma:Inglês
Publicat: Therapeutic Drug Monitoring 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5538301/
https://ncbi.nlm.nih.gov/pubmed/28489727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0000000000000414
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars